In this issue:
Pirtobrutinib in heavily pre-treated MCL patients
Clinical benefits of CPX-351 in AML
Peri-transplant radiation therapy plus ASCT
Brentuximab vedotin-AVD treatment for HIV patients diagnosed with cHL
AE analysis for ibrutinib versus acalabrutinib
CPI therapy in aggressive B-cell lymphomas after CAR-T failure
RBAC treatment in elderly mantle cell lymphoma patients
Efficacy and safety of venetoclax and rituximab in CLL patients
Combination therapy lenalidomide plus CHOEP
Comparison of ven/HMA and intensive chemotherapy
Please login below to download this issue (PDF)